• -
  • English
  • Japanese
  • Korean
首頁 > 出版商一覽 > GBI Research
出版商
出版商指數
從類別尋找
從地區尋找

GBI Research 市場調查資料一覽

日商環球訊息有限公司為GBI Research所發行的研究報告代理商, 考慮購買或需要諮詢研究報告時請與我們聯絡。≫ 選擇本公司購買的優點

GBI Research
GBI Research發行對於醫藥品、醫療機器、替代能源、發電、清淨技術、石油・瓦斯、化學品等、廣泛專門業界的詳細資訊報告書。本報告書依據完整的第一次・第二次調查、獨自的資料庫、及公司內部・公司外部的專家團隊高品質分析製作而成。企業・國家・產業等級的洞察和分析部分、包含競爭企業和市場資料、評價、臨床・市場趨勢、產品生產線及預測。
關於這個網站未刊載的報告書
篩選
標題搜索
結果共134個,以下為1 - 25 排序依 每頁數量
Antibacterial Therapies Drug Development Pipeline Review, 2017
Antibacterial Therapies Drug Development Pipeline Review, 2017
出版商
GBI Research
商品編碼
485008
出版日期
2017年03月22日
內容資訊
418 Pages
價格
USD 3,995 Sample Availavle Browse Availavle
Cardiovascular Disorders Drug Development Pipeline Review, 2017
Cardiovascular Disorders Drug Development Pipeline Review, 2017
出版商
GBI Research
商品編碼
485009
出版日期
2017年03月16日
內容資訊
432 Pages
價格
USD 3,995 Sample Availavle Browse Availavle
Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market
Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market
出版商
GBI Research
商品編碼
358649
出版日期
2017年03月09日
內容資訊
161 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Frontier Pharma: Head and Neck Cancer - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation
Frontier Pharma: Head and Neck Cancer - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation
出版商
GBI Research
商品編碼
485007
出版日期
2017年03月01日
內容資訊
78 Pages
價格
USD 6,995 Sample Availavle Browse Availavle
Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market
Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market
出版商
GBI Research
商品編碼
485006
出版日期
2017年03月01日
內容資訊
197 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Colorectal Cancer - Heat Map and Analysis
Colorectal Cancer - Heat Map and Analysis
出版商
GBI Research
商品編碼
445728
出版日期
2017年02月01日
內容資訊
21 Pages
價格
USD 2,000 Sample Availavle Browse Availavle
Parkinson's Disease - Heat Map and Analysis
Parkinson's Disease - Heat Map and Analysis
出版商
GBI Research
商品編碼
440736
出版日期
2017年01月09日
內容資訊
20 Pages
價格
USD 2,000 Sample Availavle Browse Availavle
Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance
Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance
出版商
GBI Research
商品編碼
440734
出版日期
2017年01月09日
內容資訊
177 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Non-Hodgkin Lymphoma - Heat Map and Analysis
Non-Hodgkin Lymphoma - Heat Map and Analysis
出版商
GBI Research
商品編碼
440735
出版日期
2017年01月06日
內容資訊
15 Pages
價格
USD 2,000 Sample Availavle Browse Availavle
Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential
Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential
出版商
GBI Research
商品編碼
440733
出版日期
2017年01月05日
內容資訊
80 Pages
價格
USD 6,995 Sample Availavle Browse Availavle
Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies
Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies
出版商
GBI Research
商品編碼
431673
出版日期
2017年01月02日
內容資訊
108 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation
Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation
出版商
GBI Research
商品編碼
431672
出版日期
2017年01月02日
內容資訊
81 Pages
價格
USD 6,995 Sample Availavle Browse Availavle
COPD Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies
COPD Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies
出版商
GBI Research
商品編碼
423017
出版日期
2017年01月01日
內容資訊
122 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Dermatology Therapeutics Drug Development Pipeline Review, 2016
Dermatology Therapeutics Drug Development Pipeline Review, 2016
出版商
GBI Research
商品編碼
445727
出版日期
2016年12月15日
內容資訊
432 Pages
價格
USD 3,995 Sample Availavle Browse Availavle
Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations
Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations
出版商
GBI Research
商品編碼
410321
出版日期
2016年12月01日
內容資訊
65 Pages
價格
USD 6,995 Sample Availavle Browse Availavle
Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market
Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market
出版商
GBI Research
商品編碼
410320
出版日期
2016年12月01日
內容資訊
363 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects
Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects
出版商
GBI Research
商品編碼
409707
出版日期
2016年12月01日
內容資訊
88 Pages
價格
USD 6,995 Sample Availavle Browse Availavle
Diabetes & Obesity Drug Development Pipeline Review, 2016
Diabetes & Obesity Drug Development Pipeline Review, 2016
出版商
GBI Research
商品編碼
397899
出版日期
2016年12月01日
內容資訊
560 Pages
價格
USD 3,995 Sample Availavle Browse Availavle
Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline
Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline
出版商
GBI Research
商品編碼
336890
出版日期
2016年12月01日
內容資訊
110 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments
Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments
出版商
GBI Research
商品編碼
219212
出版日期
2016年12月01日
內容資訊
133 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19
Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19
出版商
GBI Research
商品編碼
399713
出版日期
2016年11月01日
內容資訊
183 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation
出版商
GBI Research
商品編碼
399712
出版日期
2016年11月01日
內容資訊
61 Pages
價格
USD 6,995 Sample Availavle Browse Availavle
Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy
Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy
出版商
GBI Research
商品編碼
399711
出版日期
2016年11月01日
內容資訊
126 Pages
價格
USD 4,995 Sample Availavle Browse Availavle
Ophthalmology Drug Development Pipeline Review, 2016
Ophthalmology Drug Development Pipeline Review, 2016
出版商
GBI Research
商品編碼
397898
出版日期
2016年11月01日
內容資訊
633 Pages
價格
USD 3,995 Sample Availavle Browse Availavle
Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth
Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth
出版商
GBI Research
商品編碼
388271
出版日期
2016年10月01日
內容資訊
192 Pages
價格
USD 4,995 Sample Availavle Browse Availavle